Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
PARP inhibitor combo shows early promise for patients with and without BRCA...
Dr Timothy Yap - Royal Marsden Hospital, London, UK
PARP inhibitor combo shows early promise for patients with and without BRCA mutations ( Dr Timothy Yap - Royal Marsden Hospital, London, UK )
1 May 2015
US breast cancer cases expected to increase by as much as 50 percent
Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National...
US breast cancer cases expected to increase by as much as 50 percent ( Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA )
1 May 2015
Investigational ER degrader safe, with early signs of antitumour activity...
Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA
Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer ( Dr Maura Dickler - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2015
Extended overnight fasting may lead to reduced breast cancer risk
Dr Catherine Marinac - University of California, San Diego, USA
Extended overnight fasting may lead to reduced breast cancer risk ( Dr Catherine Marinac - University of California, San Diego, USA )
30 Apr 2015
Black women found to have denser breast tissue than white women
Dr Anne Marie McCarthy - Massachusetts General Hospital, Boston, USA
Black women found to have denser breast tissue than white women ( Dr Anne Marie McCarthy - Massachusetts General Hospital, Boston, USA )
30 Apr 2015
How will genomics be applied to patient therapy in future?
Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas
How will genomics be applied to patient therapy in future? ( Dr Jean Claude Zenklusen - Director, The Cancer Genome Atlas )
30 Apr 2015
ecancermedicalscience editor's choice for April 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for April 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
30 Apr 2015
New approaches in computational pathology for risk assessment in benign breast...
Dr Andrew Beck - Beth Israel Deaconess Medical Center, Boston, USA
New approaches in computational pathology for risk assessment in benign breast diseases ( Dr Andrew Beck - Beth Israel Deaconess Medical Center, Boston, USA )
29 Apr 2015
Chk1 inhibition combined with standard dose gemcitabine may be safe and...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Chk1 inhibition combined with standard dose gemcitabine may be safe and effective ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
29 Apr 2015
Investigational PD-L1–targeted immunotherapy safe for patients with triple...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer, effective in some ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
27 Apr 2015
US breast cancer cases expected to increase by as much as 50 percent by 2030
Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National...
US breast cancer cases expected to increase by as much as 50 percent by 2030 ( Dr Phillip Rosenberg - Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA )
27 Apr 2015
ecancermedicalscience editor's choice for March 2015
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for March 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
9 Apr 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation